Targeting SARS-CoV-2 NSP6 Protein for Next-Generation COVID Drugs
Researchers have identified eight promising drug candidates targeting the SARS-CoV-2 NSP6 protein through sophisticated computational methods. This approach could lead to next-generation COVID-19 treatments that work differently from current options.
